The utility of protected-environment regimens for the compromised host: a critical assessment.
D000208:Acute Disease; D000741:Anemia, Aplastic / Q000628:therapy; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications / Q000517:prevention & control*; D004780:Environment, Controlled; D005374:Filtration / Q000295:instrumentation; D006749:Hospital Design and Construction; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D007938:Leukemia / Q000150:complications; D008223:Lymphoma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*
D000903:Antibiotics, Antineoplastic